Researchers reviewed cancer pain management strategies, including traditional Chinese medicine-based strategies such as acupoint therapies.

Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments ...

What Is Fueling This Impressive Growth In The Chemotherapy-Induced Neutropenia Treatment Market? The reasons are manifold and include factors such as increasing cancer incidence rates, growing ...

The CIPN treatment market is poised for growth driven by personalized multimodal care, digital health innovations, and strategic partnerships despite challenges posed by tariffs. Key opportunities lie ...

New research out of VCU Massey Comprehensive Cancer Center—published in Brain, Behavior and Immunity—is the first to suggest that a tumor-driving gene known as AEG-1 actively regulates the ...

The oncogene AEG-1 shows promise as a target for managing chemotherapy-induced peripheral neuropathy, according to a recently published study.

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...

Dr. Sharon Gurm, BSc. ND, FABNO, Naturopathic Oncologist, Port Moody, BC discusses how a naturopathic oncologist can help treat chemotherapy-induced peripheral neuropathy. Trump says U.S. will ...

Preclinical data show prevention of both chemotherapy ... but also neuropathy induced by ADC payloads" said David Liberg, Chief Scientific Officer at Cantargia. Peripheral neuropathic pain ...

but also neuropathy induced by ADC payloads" said David Liberg, Chief Scientific Officer at Cantargia. Peripheral neuropathic pain, a common and often severe side effect, can be triggered by both ...